Evogene Ltd.

TASE:EVGN Stock Report

Market Cap: ₪40.8m

Evogene Future Growth

Future criteria checks 2/6

Evogene is forecast to grow earnings and revenue by 38.7% and 38.5% per annum respectively.

Key information

38.7%

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth58.4%
Revenue growth rate38.5%
Future return on equityn/a
Analyst coverage

Low

Last updated25 Nov 2024

Recent future growth updates

No updates

Recent updates

We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate

Mar 05
We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate

Will Evogene (TLV:EVGN) Spend Its Cash Wisely?

Oct 09
Will Evogene (TLV:EVGN) Spend Its Cash Wisely?

Will Evogene (TLV:EVGN) Spend Its Cash Wisely?

Jun 26
Will Evogene (TLV:EVGN) Spend Its Cash Wisely?

We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate

Mar 13
We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate

Here's Why We're Watching Evogene's (TLV:EVGN) Cash Burn Situation

Oct 07
Here's Why We're Watching Evogene's (TLV:EVGN) Cash Burn Situation

We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate

Jun 16
We're Keeping An Eye On Evogene's (TLV:EVGN) Cash Burn Rate

Will Evogene (TLV:EVGN) Spend Its Cash Wisely?

Mar 02
Will Evogene (TLV:EVGN) Spend Its Cash Wisely?

Here's Why We're Not Too Worried About Evogene's (TLV:EVGN) Cash Burn Situation

May 28
Here's Why We're Not Too Worried About Evogene's (TLV:EVGN) Cash Burn Situation

Companies Like Evogene (TLV:EVGN) Are In A Position To Invest In Growth

Jan 21
Companies Like Evogene (TLV:EVGN) Are In A Position To Invest In Growth

What Can We Make Of Evogene's (TLV:EVGN) CEO Compensation?

Nov 30
What Can We Make Of Evogene's (TLV:EVGN) CEO Compensation?

Earnings and Revenue Growth Forecasts

TASE:EVGN - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202745-9N/AN/A1
12/31/202626-18N/AN/A2
12/31/202515-22N/AN/A2
12/31/202411-23N/AN/A2
9/30/20247-24-21-20N/A
6/30/20249-20-20-20N/A
3/31/20249-21-20-19N/A
12/31/20236-24-22-22N/A
9/30/20236-20-19-18N/A
6/30/20232-23-22-21N/A
3/31/20232-25-23-22N/A
12/31/20222-27-25-24N/A
9/30/20221-31-31-30N/A
6/30/20221-32-29-28N/A
3/31/20221-29-29-28N/A
12/31/20211-28-26-25N/A
9/30/20211-29-24-24N/A
6/30/20211-26-23-22N/A
3/31/20211-24-19-19N/A
12/31/20201-23-20-20N/A
9/30/20201-21-18-17N/A
6/30/20201-21-18-17N/A
3/31/20200-21-19-18N/A
12/31/20191-18-19-18N/A
9/30/20191-18-16-16N/A
6/30/20192-18-16-16N/A
3/31/20192-19-16-16N/A
12/31/20182-21-16-15N/A
9/30/20182-21-16-16N/A
6/30/20182-21N/A-15N/A
3/31/20183-21N/A-16N/A
12/31/20173-21N/A-16N/A
9/30/20174-21N/A-17N/A
6/30/20175-21N/A-16N/A
3/31/20175-21N/A-15N/A
12/31/20167-20N/A-12N/A
9/30/20168-18N/A-12N/A
6/30/20169-17N/A-11N/A
3/31/201610-17N/A-12N/A
12/31/201511-17N/A-12N/A
9/30/201512-17N/A-10N/A
6/30/201512-17N/A-9N/A
3/31/201513-16N/A-8N/A
12/31/201415-15N/A-9N/A
9/30/201417-14N/A-8N/A
6/30/201418-12N/A-7N/A
3/31/201418-11N/A-6N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: EVGN is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: EVGN is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: EVGN is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: EVGN's revenue (38.5% per year) is forecast to grow faster than the IL market (2.4% per year).

High Growth Revenue: EVGN's revenue (38.5% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if EVGN's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/11 01:47
End of Day Share Price 2025/01/09 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Evogene Ltd. is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Scott HenryAlliance Global Partners
Benjamin HaynorAlliance Global Partners
Kristen KluskaCantor Fitzgerald & Co.